Naveen Krishnan, Mirae Asset Capital Life Science managing director
Investment firm Mirae launches its US biotech VC fund with $50M
A new biotech venture capital firm emerged Thursday with $50 million to back as many as eight private life sciences startups.
The firm, Mirae Asset …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
